ArticleEndocrine2024

The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth.

Seda Hanife Oğuz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.